CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,044,529 | +748.4% | 304,120 | +414.1% | 0.01% | +1100.0% |
| Q2 2023 | $1,066,063 | +12.9% | 59,160 | +0.6% | 0.00% | 0.0% |
| Q1 2023 | $944,135 | +86.6% | 58,788 | +112.7% | 0.00% | 0.0% |
| Q4 2022 | $505,885 | -99.9% | 27,644 | -39.2% | 0.00% | 0.0% |
| Q3 2022 | $893,325,000 | +297.8% | 45,485 | +277.7% | 0.00% | – |
| Q2 2022 | $224,583,000 | +160.8% | 12,042 | +207.0% | 0.00% | – |
| Q1 2022 | $86,110,000 | -71.1% | 3,923 | -62.6% | 0.00% | – |
| Q4 2021 | $297,850,000 | +106.3% | 10,484 | +52.9% | 0.00% | – |
| Q3 2021 | $144,382,000 | +420.4% | 6,859 | +366.0% | 0.00% | – |
| Q2 2021 | $27,747,000 | -50.1% | 1,472 | -59.6% | 0.00% | – |
| Q1 2021 | $55,634,000 | -38.6% | 3,641 | -43.3% | 0.00% | – |
| Q4 2020 | $90,544,000 | -12.2% | 6,417 | -2.5% | 0.00% | – |
| Q3 2020 | $103,109,000 | +288.2% | 6,580 | +334.0% | 0.00% | – |
| Q2 2020 | $26,560,000 | -47.6% | 1,516 | -56.0% | 0.00% | – |
| Q1 2020 | $50,671,000 | +24.4% | 3,447 | +112.3% | 0.00% | – |
| Q4 2019 | $40,746,000 | +72.8% | 1,624 | +3.6% | 0.00% | – |
| Q3 2019 | $23,583,000 | -7.7% | 1,568 | +53.4% | 0.00% | – |
| Q2 2019 | $25,550,000 | -39.3% | 1,022 | -44.7% | 0.00% | – |
| Q1 2019 | $42,060,000 | – | 1,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |